Nanotechnology & nanobiotechnology

Nanotechnology involves structures smaller than smaller than 100 nanometres. Nanobiotechnology is the use of nanotechnology in life sciences, or the reverse: using biological materials or blueprints to manufacture technical nanosystems.

Initial toxicological studies have provided evidence that nanoparticles could harm humans and the environment. Handling synthetic nanoparticles should therefore be in line with the precautionary principle. An external report commissioned by the ECNH concludes that the burden of proof for the harmlessness of (unbound) synthetic nanoparticles should be the responsibility of the manufacturers if there are sensible reasons for presuming that these particles may, in certain circumstances, severely damage humans and the environment.

Furthermore, in the series "Beiträge zur Ethik und Biotechnologie":

Nanobiotechnologie - Eine ethische Auslegeordnung (Nanobiotechnology ? an ethical interpretation), in German, 2006.

 

To the top

Last edition: 06.11.2018

Contact

Secretariat ECNH
ekah(at)bafu.admin.ch
Tel.: +41 (0)58 463 83 83

Postal address

Federal Ethics Committee on Non-Human Biotechnology ECNH
c/o Federal Office for the Environment (FOEN)
CH-3003 Bern
Switzerland

Map

Papiermühlestrasse 172
CH-3003 Bern

Timetable for public transport
Enter "Papiermühle" as destination station